Artemis Therapeutics Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.311 million compared to USD 0.007 million a year ago. Net loss was USD 1.36 million compared to USD 0.329 million a year ago.

Basic loss per share from continuing operations was USD 0.01.